Baucus' Donut Hole Drug Discount Plan Would End Up Costing Medicare $17 Bil. Over 10 Years - CBO
This article was originally published in The Pink Sheet Daily
Executive Summary
Budget office score details costs and savings to Medicare under Sen. Baucus' "chairman's mark" of health reform legislation; discount's cost to pharma is twice as much.
You may also be interested in...
Generics Industry Offers Substitution, Not Rebates, As Health Reform Savings Proposal
Giving states incentives to boost Medicaid's use of generic drugs would produce more savings than Sen. Baucus' rebate proposals, Teva argues.
Generics Industry Offers Substitution, Not Rebates, As Health Reform Savings Proposal
Giving states incentives to boost Medicaid's use of generic drugs would produce more savings than Sen. Baucus' rebate proposals, Teva argues.
Pharma's Health Reform Bounce: $115 Bil. Over 10 Years
Senate Finance Committee bill would net the pharmaceutical industry roughly $3.5 billion per year after accounting for PhRMA pledge.